2008 American Transplant Congress

Untitled Document

ATC PROGRAM

Sunday, June 1, 2008 Sunday \| Monday \| Tuesday \| Wednesday
Sunrise Symposia 7:00 am – 8:15 am
Renal Transplant Clinical Pathology Chairs: Mark D. Stegall,MD,Mayo Clinic Rochester, Rochester,MN and Anthony J. Demetris,MD, University of Pittsburgh, Pittsburgh, PA *NOTE: This session is a special interactive session with audience response participation
7:00 am – 7:20 am	Case Presentation Fernando G. Cosio, MD Mayo Clinic Rochester, Rochester, MN
7:20 am – 7:40 am	Case Discussion Robert B. Colvin, MD Massachusetts General Hospital, Boston,MA
7:40 am – 8:00 am	Endothelial Cell Injury and Antibody Philip Halloran, MD University of Alberta, Edmonton, Canada
8:00 am – 8:15 am	Audience Response Participation
mTOR and Vascular Biology: Discovery to Translation Chair: David M. Briscoe, MD, Children's Hospital of Boston, Boston, MA and Marie-Josee Hebert, MD, University of Montreal, Montreal, Canada
7:00 am – 7:25 am	mTOR Complexes and Intracellular Signaling Via the AGC Kinase and PKC Bing Su, PhD Yale University, New Haven, CT
7:25 am – 7:50 am	mTOR/Akt Interactions in Vascular Biology Laura Benjamin, PhD Beth Israel Deaconess Medical Center, Boston, MA
7:50 am – 8:15 am	mTOR and the Development of Allograft Pathology David M. Briscoe,MD Children's Hospital of Boston, Boston, MA
Pancreas Alone Vs. Islet Transplantation – Current Controversies Chairs: Steven Paraskevas, MD, PhD, McGill University Health Centre, Montreal, Canada and Patrick Dean, MD, Mayo Clinic Rochester, Rochester, MN *NOTE: This session is a special interactive session with audience response participation
7:00 am – 7:20 am	Islets Paolo Fiorina, MD Boston Children's Hospital, Boston, MA
7:20 am – 7:40 am	Pancreas Raja Kandaswamy, MD, FACS University of Minnesota,Minneapolis,MN
7:40 am – 7:55 am	Concluding Remarks/Rebuttal – Islets
7:55 am – 8:10 am	Concluding Remarks/Rebuttal – Pancreas
Assessment and Clinical Considerations of New Histocompatibility Tests for Antibody Identification (HLA/Non- HLA) and Crossmatching Chair: Ronald H. Kerman, PhD, University of Texas, Houston, TX and Adriana Zeevi, PhD, University of Pittsburgh, Pittsburgh, PA
7:00 am – 7:25 am	"Transplant Histocompatibility Conference:" Presentation of the Problems Ronald H. Kerman, PhD University of Texas, Houston, TX
7:25 am – 7:50 am	Antibody Identification, Specificity, the Crossmatch and Clinical Correlations Karen A. Nelson, PhD Puget Sound Blood Center, Seattle,WA
7:50 am – 8:15 am	Involvement of Non-HLA Antigens in Solid Organ Transplantation Elaine F. Reed, PhD University of California, Los Angeles, Los Angeles,CA
Early Morning Workshops 7:00 am – 8:15 am
Immunologic Monitoring: Ready for Primetime? Co-chairs: Peter S. Heeger, MD, Mt. Sinai School of Medicine, New York, NY and Peter Nickerson, MD, Canadian Blood Services,Winnipeg, Canada New Tools for the Transplantologist: Gene Silencing and Conditional Gene Expression Co-chairs: Jonathan Maltzman, MD, PhD, University of Pennsylvania, Philadelphia, PA and Mohammed Oukka, PhD, Brigham and Women's Hospital, Boston, MA NK and NKT Cells in Tolerance and Rejection Co-chairs: Megan Sykes, MD, Massachusetts General Hospital, Boston, MA and Nicholas Jones, PhD, University of Oxford, Oxford, United Kingdom Composite Tissue Allografts: Challenges and Opportunities Co-chairs: Stephen T. Bartlett, MD, University of Maryland, Baltimore, MD and W.P. Andrew Lee, MD, University of Pittsburgh Medical Center, Pittsburgh, PA Management of Medical Co-Morbidities in the Long-term Adult and Pediatric Liver Transplant Recipient Co-chairs: John R. Lake, MD, University of Minnesota, Minneapolis, MN and John Bucuvalas, MD, Cincinnati Children's Hospital, Cincinnati, OH Rehabilitation and Exercise for Transplant Recipients Chair: Patricia Painter, PhD, University of Minnesota, Minneapolis, MN New Interventions for the Metabolic Syndrome: Are They for Solid Organ Transplant Recipients? Co-chairs: Herwig-Ulf Meier-Kriesche, MD, University of Florida, Gainesville, FL and James F. Trotter, MD, University of Colorado, Denver, CO Pulsatile Perfusion of Donor Organs: Hype or Real Advance? Chairs: Bruce R. Rosengard, MD, Massachusetts General Hospital, Boston, MA and Rutger Ploeg, MD, PhD, University Medical Center Groningen, Groningen, Netherlands
Joint Plenary and Awards 8:30 am – 10:00 am
State-of-the-Art Address 10:00 am – 10:30 am Beyond the T Cell Receptor – Defining Molecular Signaling in Transplantation and Cancer Tak Mak, PhD Princess Margaret Hospital, Toronto, Canada
10:30 am – 11:00 am	Break
Concurrent Symposia 11:00 am – 12:30 pm
Living Donation: A Critical Analysis Chairs: Arthur J. Matas, MD, University of Minnesota, Minneapolis, MN and Robert S. Brown, Jr., MD, MPH, Columbia University, New York, NY *NOTE: This session is a special interactive session with audience response participation
11:00 am – 11:30 am	Living Donor Follow-Up: Current and Future Regulatory Perspectives Timothy L. Pruett, MD University of Virginia Health Science Center, Charlottesville, VA
11:30 am – 12:00 nn	Living Donor Liver Transplantation: Lessons Learned and Future Direction Kim M. Olthoff, MD University of Pennsylvania, Philadelphia, PA
12:00 nn – 12:30 pm	Living Donor Kidney Transplantation: Defining the Limits Stephen C. Textor, MD Mayo Clinic Rochester, Rochester, MN
Nanomedicine: Can Tiny Devices Solve Big Problems in Transplantation? Chairs: Anthony M. Jevnikar, MD, London Health Sciences Center, London, Canada and Steven Paraskevas, MD, PhD, McGill University Health Centre, Montreal, Canada
11:00 am – 11:30 am	Nanotechnology, Nanomolecular Materials and Nanomedicine James R. Baker, MD Michigan Nanotechnology Institute for Medicine and Biological Sciences, Ann Arbor, MI
11:30 am – 12:00 nn	Engineering Novel Diagnostic Modalities and Implantable Cytomimetic Nanomaterials for Next- Generation Medicine Carlo D. Montemagno, PhD, University of Cincinnati, Cincinnati, OH
12:00 nn – 12:30 pm	Nanoparticles to Alter Immune Responses and Battle Cancer Omid C. Farokhzad, MD, Brigham and Women's Hospital, Boston, MA
Regulatory T Cells and theControl of Immunity Chairs: Wayne W. Hancock, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA and David M. Rothstein, MD, Yale Medical School, New Haven, CT
11:00 am – 11:30 am	FoxP3 in the Control of the Regulatory T Cell Lineage Alexander Rudensky, PhD University of Washington, Seattle,WA
11:30 am – 12:00 nn	The Role of Distinct Subsets of FoxP3+ Regulatory T Cells in the Control of Immune Responses Ethan M. Shevach, MD NIAID/NIH Lab of Immunology,Bethesda, MD
12:00 nn – 12:30 pm	The Connection of TRegs and Th17 Cells Vijay Kuchroo, DVM, PhD, Harvard Medical School, Cambridge, MA
Modifying Ischemia-Reperfusion Injury for Graft Survival Chairs: Shaf Keshavjee, MD, Toronto General Hospital, Toronto, Canada and Rutger Ploeg, MD, PhD, University Medical Center Groningen, Groningen, Netherlands
11:00 am – 11:30 am	Gene Silencing in Preventing IRI: Multi-target Approaches Wei-Ping Min, PhD University Hospital, Ontario, Canada
11:30 am – 12:00 nn	Molecular Profiling of Kidney Ischemia- Reperfusion Hamid Rabb, MD The Johns Hopkins University School of Medicine, Baltimore, MD
12:00 nn – 12:30 pm	Strategies to Prevent IRI in Transplantation:What's New? Jerzy Kupiec-Weglinski, MD, PhD University of California, Los Angeles, Los Angeles, CA
Industry-supported Satellite Symposia – with lunch 12:45 pm – 2:00 pm
Concurrent Sessions 2:15 pm – 5:00 pm
Poster Session II 5:00 pm – 6:00 pm with Beer and Wine Reception
Monday, June 2 Sunday \| Monday \| Tuesday \| Wednesday
Sunrise Symposia 7:00 am – 8:15 am
Hepatocellular Carcinoma in Liver Transplantation Chairs: Elizabeth A. Pomfret, MD, PhD, FACS, Lahey Clinic Medical Center, Burlington, MA and John R. Lake, MD, University of Minnesota, Minneapolis, MN
7:00 am – 7:25 am	Should Living Donors Be Used For HCC? Robert A. Fisher, MD Medical College of Virginia, Richmond, VA
7:25 am – 7:50 am	Downsizing the Case for Large Tumors Rafik Mark Ghobrial, MD, PhD University of California, Los Angeles, Los Angeles, CA
7:50 am – 8:15 am	Determinants of Recurrence after Transplantation: The Japanese Experience Satoru Todo, MD Hokkaido University School Medical, Sapporo, Japan
Assessing Cardiovascular Risk Before and After Transplantation Chairs: Bertram L. Kasiske, MD, University of Minnesota, Minneapolis, MN and Robert G. Gaston, MD, University of Alabama, Birmingham, AL
7:00 am – 7:25 am	Pretransplant Screening for Cardiac Disease – Do We Need New Algorithms? Bertram L. Kasiske, MD University of Minnesota, Minneapolis, MN
7:25 am – 7:50 am	Risk Factors for Cardiovascular Mortality Angelo M. De Mattos, MD, MPH University of California – Davis, Sacramento, CA
7:50 am – 8:15 am	Lessons Learned from the ALERT Trial Edward Cole, MD Toronto General Hospital, Toronto, CA
Innate Immunity in Transplantation Chairs: Megan Sykes, MD, Massachusetts General Hospital, Boston, MA and Richard N. Pierson III, MD, University of Maryland-Baltimore, Baltimore, MD
7:00 am – 7:25 am	Innate Immunity and Evolution of Allorecognition Fadi Lakkis, MD Yale University Medical School, New Haven, CT
7:25 am – 7:50 am	TLR and Innate Immune Activation: Targets for Intervention? Daniel Goldstein, MD Yale University Medical School, New Haven, CT
7:50 am – 8:15 am	Complement and the Innate Immune System Peter S. Heeger, MD Mt. Sinai School of Medicine, New York, NY
Basic Science of New Therapeutic Targets in Posttransplantation Malignancies Chairs: Anne VanBuskirk, PhD, TAP Pharmaceutical Products, Westerville, OH and Olivia M. Martinez, PhD, Stanford University, Stanford, CA
7:00 am – 7:25 am	Inflammatory Signaling Pathways in Skin Cancer TBD
7:25 am – 7:50 am	Effects of Gender Differences on Inflammation and Skin Cancer Development Tatiana M. Oberyszyn, PhD Ohio State University, Columbus, OH
7:50 am – 8:15 am	Bench to Bedside: Anti-angiogenesis and Anti-tumor Effects of Immunosuppressants Edward Geissler, PhD University of Regensburg, Wenzenbach, Germany
Early Morning Workshops 7:00 am – 8:15 am
Therapeutic Prospects of Alternate Co-stimulation Pathways Co-chairs: Nader Najafian, MD, Brigham and Women's Hospital, Boston, MA and Jerzy Kupiec-Weglinski, MD, PhD, University of California, Los Angeles, Los Angeles, CA Update on Dendritic Cells Co-chairs: Adrian E. Morelli, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA and Angus W. Thomson, PhD, DSc, University of Pittsburgh Medical Center, Pittsburgh, PA Memory T Cells Co-chairs: Anna Valuskikh, PhD, The Cleveland Clinic, Cleveland, OH, and Donna Farber, PhD, University of Maryland, Baltimore, MD Extended Donors in Liver Transplantation Co-chairs: Alan N. Langnas, DO, University of Nebraska Medical Center, Omaha, NE and Sammy Saab, MD, MPN, University of California, Los Angeles, Los Angeles, CA Combined Kidney/Liver Transplantation Co-chairs: James D. Eason, MD, FACS, University of Tennessee/Methodist University Hospital Transplant Institute, Memphis, TN and Alan H.Wilkinson, FRCP, University of California, Los Angeles, Los Angeles, CA Long-term Quality of Life for Pediatric Transplant Recipients Co-chairs: Estella M. Alonso, MD, Children's Memorial Medical Center, Chicago, IL and Robert B. Ettenger, MD, University of California, Los Angeles, Los Angeles, CA Paired Kidney Donation Co-chairs: Dorry Segev, MD, The Johns Hopkins University, Baltimore, MD and Kiil Park, MD, PhD, Myongji Hospital, Seoul, Korea Minority Access to Transplantation:Why Still a Problem in 2008? Co-chairs: Carlton J. Young, MD, University of Alabama at Birmingham, Birmingham, AL and Winfred Williams, MD, Massachusetts General Hospital, Boston, MA
Joint Plenary Session 8:30 am – 10:00 am
Canadian Anniversary Celebration
10:00 am – 10:30 am	Canadian 50th Anniversary Celebration
10:30 am – 11:00 am	Break
Concurrent Symposia 11:00 am – 12:30 pm
Micro RNAi and Control of Lymphocyte Development Chairs: Anita S.F. Chong, PhD, University of Chicago, Chicago, IL and John Iacomini, PhD, Brigham and Women's Hospital, Boston, MA
11:00 am – 11:30 am	Micro RNAs in Cell Differentiation and Cancer Judy Lieberman, MD, PhD Harvard Medical School, Boston, MA
11:30 am – 12:00 nn	miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection Chang-Zheng Chen, PhD Stanford University, Stanford, CA
12:00 nn – 12:30 pm	Not miR-ly Small RNAs: Big Biological Roles for miRs Carl D. Novina, MD, PhD Dana Farber Cancer Institute, Boston, MA
Progress in Moving Transplantation Tolerance to the Clinic Chairs: Mohamed Sayegh, MD, Brigham and Women's Hospital, Boston, MA and Douglas J. Norman, MD, Oregon Health and Sciences Center, Portland, OR
11:00 am – 11:30 am	What Are the Hurdles to Achieving Clinical Tolerance: Scientific and Nonscientific? Mohamed Sayegh, MD Brigham and Women's Hospital, Boston, MA
11:30 am – 12:00 nn	Progress on Developing Assays to Measure Tolerance Laurence Turka, PhD University of Pennsylvania, Philadelphia, PA
12:00 nn– 12:30 pm	Review of the Status of All the Clinical Tolerance Protocols Kenneth A. Newell, MD, PhD Emory University, Atlanta, GA
Pre-emptive Kidney Transplantation Chairs: Gabriel M. Danovitch, MD, University of California, Los Angeles, Los Angeles, CA and Michael M. Abecassis, MD, MBA, FRCS, Northwestern University, Chicago, IL
11:00 am – 11:30 am	Chronic Kidney Disease: Definitions, Risk and Management Bryan N. Becker, MD University of Wisconsin, Madison, WI
11:30 am – 12:00 nn	Making the Case for Pre-emptive Transplantation Robert G. Gaston, MD University of Alabama, Birmingham, AL
12:00 nn – 12:30 pm	Barriers to Pre-Emptive Kidney Transplantation Alan B. Leichtman, MD University of Michigan, Ann Arbor, MI
Hepatitis C: Are We Really Making Progress? Chairs: Abraham Shaked, MD, PhD, University of Pennsylvania, Philadelphia, PA and Russell H.Wiesner, MD, Mayo Clinic Rochester, Rochester, MN
11:00 am – 11:30 am	Immunosuppressive Strategies for HCV John R. Lake, MD University of Minnesota, Minneapolis, MN
11:30 am – 12:00 nn	How to Avoid Recurrence in Transplant Recipients Ronald W. Busuttil, MD University of California, Los Angeles, Los Angeles, CA
12:00 nn – 12:30 pm	Novel Therapy in Treatment of HCV Michael R. Charlton, MD Mayo Clinic Rochester, Rochester, MN
Industry-supported Satellite Symposia – with lunch 12:45 pm – 2:00 pm
Concurrent Sessions 2:15 pm – 5:00 pm
Poster Session III 5:00 pm – 6:00 pm with Beer and Wine Reception
AST Business Meeting 6:00 pm – 7:00 pm
Tuesday, June 3 Sunday \| Monday \| Tuesday \| Wednesday
Sunrise Symposia 7:00 am – 8:15 am
Update in B-cell Tolerance Chairs: Colin Anderson, PhD, Alberta Diabetes Institute,Edmonton, Canada and Marilia I. Cascalho, MD, PhD, Mayo Clinic Rochester, Rochester, MN
7:00 am – 7:25 am	Control of Immature B-cell Tolerance by Acute and Chronic Exposure to Antigen John C. Cambier, PhD University of Colorado Health Sciences Center, Denver, CO
7:25 am – 7:50 am	Control of the B-cell Intrinsic Tolerance Program by Cbl Ubiquitin Ligases Hua Gu, PhD Columbia University, New York, NY
7:50 am – 8:15 am	Transcriptional Basis of B-cell Tolerance Michael C. Carroll, PhD Harvard Medical School, Boston, MA
Pediatrics: Are Children Suitable Candidates for Tolerance Regimens? Chairs: George V. Mazariegos, MD, Children's Hospital of Pittsburgh, Pittsburgh, PA and Allan D. Kirk, MD, PhD, Emory University, Atlanta, GA
7:00 am – 7:25 am	Developmental Aspects of the Immune System and Implications for Tolerance Lori J.West, MD, DPhil University of Alberta, Edmonton, Canada
7:25 am – 7:50 am	Tolerance Induction in Children: Which Strategies Are Most Logical? Joren C. Madsen, MD, DPhil Massachusetts General Hospital, Boston, MA
7:50 am – 8:15 am	The Case for Early Tolerance Induction Studies in Children William E. Harmon, MD Children's Hospital, Harvard Medical School, Boston, MA
Fellowship Training of the Transplant Specialist Chairs: Donald E. Hricik, MD, University Hospital of Cleveland, Cleveland, OH and Sandy Feng, MD, University of California, San Francisco, San Francisco, CA
7:00 am – 7:25 am	Educational Paradigms in Transplant Medicine Fuad Shihab, MD University of Utah, Salt Lake City, UT
7:25 am – 7:50 am	Certification of the Transplant Specialist James A. Schulak, MD University Hospitals Case Medical Center, Cleveland, OH
7:50 am – 8:15 am	Training of Fellows in Surgery:Where Are We Today? Goran B. Klintmalm, MD, PhD, FACS Baylor University Health System, Dallas, TX
Lung Transplantation: Hot Topics Chairs: James S. Allan, MD, Massachusetts General Hospital, Boston, MA and Stuart Sweet, MD, PhD,Washington University, St Louis, MO
7:00 am – 7:25 am	Assessing Benefit in Lung Transplantation Edward R. Garrity, Jr., MD University of Chicago Hospital, Chicago, IL
7:25 am – 7:50 am	Gastroesophogeal Reflux Disease and Obliterative Bronchiolitis Charles W. Hoopes, MD University of California, San Francisco San Francisco, CA
7:50 am – 8:15 am	Molecular Markers of Lung Injury Shaf Keshavjee, MD University of Toronto, Toronto, Canada
Early Morning Workshops 7:00 am – 8:15 am
Mechanistic Insights into Chronic Allograft Vasculopathy Co-chairs: Jordan Pober, MD, PhD, Boyer Center for Molecular Medicine, New Haven, CT and William M. Baldwin III, MD, PhD,The Johns Hopkins University, Baltimore, MD Therapeutic Potential of T Regulatory Cells Co-chairs: Robert Lechler, PhD, FRCP, Guy's, King's and St. Thomas' School of Medicine, London, United Kingdom and Anil Chandraker, MBChB, MRC, Brigham and Women's Hospital, Boston, MA Innate Immunity: Towards Clinical Translation Co-chairs: Marisa Alegre, MD, PhD, University of Chicago, Chicago, IL and Xian Li, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA Pregnancy in Transplantation Co-chairs: Vincent T. Armenti, MD, PhD, Thomas Jefferson University Hospital, Philadelphia, PA and Veronica Gomez-Lobo, MD,Washington Hospital Center,Washington DC MELD/PELD Inequities: Can the Recipe be Improved? Co-chairs: Russell H.Wiesner, MD, Mayo Clinic Rochester, Rochester, MN and Richard B. Freeman, MD, Tufts University School of Medicine, Boston, MA Vaccination and Prophylaxis Recommendations for Adult and Pediatric Organ Transplant Recipients Co-chairs: Robin K. Avery, MD, Cleveland Clinic Foundation, Cleveland, OH and Marian G. Michaels, MD, MPH, Children's Hospital of Pittsburgh, Pittsburgh, PA PTLD: Therapies Beyond Reduced Immunosuppression Co-chairs: Thomas G. Gross, MD, PhD, The Ohio State University, Columbus, OH and Vikas R. Dharnidharka, MD, MPH, University of Florida HSC, Gainesville, FL Autoimmunity and Alloimmunity after Islet and Pancreas Transplantation Co-chairs: George W. Burke III, MD, University of Miami School of Medicine, Miami, FL and Patricia M. Campbell, MBChB,University of Alberta, Edmonton, Canada
Joint Plenary and Awards 8:30 am – 10:00 am
State-of-the-Art Address 10:00 am – 10:30 am Issues in the Globalization of Transplantation Luc Noel, World Health Organization, Geneva, Switzerland
10:30 am – 11:00 am	Break
Presidential Addresses
11:00 am – 11:30 am	AST Flavio Vincenti, MD University of California, San Francisco, San Francisco, CA
11:30 am – 12:00 nn	ASTS Goran B. Klintmalm, MD, PhD, FACS Baylor University Medical Center, Dallas, TX
ASTS and AST Distinguished Service Awards 12:00 nn – 12:30 pm
Industry-supported Satellite Symposia – with lunch 12:45 pm – 2:00 pm
Concurrent Sessions 2:15 pm – 5:00 pm
Poster Session IV 5:00 pm – 6:00 pm with Beer and Wine Reception
ASTS Business Meeting 6:00 pm – 7:00 pm
Wednesday, June 4 Sunday \| Monday \| Tuesday \| Wednesday
Sunrise Symposia 7:00 am – 8:15 am
Canadian Perspectives on Clinical Transplantation Co-sponsored by the Canadian Society of Transplantation (CST) and Canadian Institutes of Health Research (CIHR) Chairs: Lori J.West, MD, DPhil, University of Alberta, Edmonton, Canada and Paul A. Keown, MD, PhD, MBA, Vancouver Hospital and HSC, Vancouver, Canada
7:00 am – 7:25 am	Can We Really Assess Differences in Transplant Outcomes in Canada and the United States? John Gill, MD, MS St. Paul's Hospital, Vancouver, Canada
7:25 am – 7:50 am	Patient and Allograft Survival in Canada: Impact of Racial Diversity and Universal Health Care Sita Gourishankar, MD, MSc University of Alberta, Edmonton, Canada
7:50 am – 8:15 am	Outcomes of Commercial RenalTransplantation: A Canadian Experience Jeffrey Zaltzman, MD St. Michael's Hospital, Toronto, Canada
Randomized Clinical Trials (RCT's) in Heart Transplantation Chairs: Heather J. Ross, MD, Toronto General Hospital, Toronto, Canada and George Tellides, MD, PhD, Yale University School ofMedical, New Haven, CT
7:00 am – 7:25 am	What Have RCT's Taught Us so Far? Jon Kobashigawa, MD University of California, Los Angeles, Los Angeles, CA
7:25 am – 7:50 am	What Are the Most Important Trials for the Future? Randall C. Starling, MPH Cleveland Clinic, Cleveland, OH
7:50 am – 8:15 am	What Are the Most Important Clinical End-Points For RCT's in 2008? Mandeep R. Mehra, MD University of Maryland, Baltimore, MD
Polyomavirus Chairs: Hans Hirsch, MD, Institute for Medical Microbiology, Basel, Switzerland and Daniel Brennan, MD,Washington University School of Medicine, St. Louis, MO
7:00 am – 7:25 am	Current Screening and Monitoring Recommendations Parmjeet Randhawa, MD University of Pittsburgh, Pittsburgh, PA
7:25 am – 7:50 am	Leflunomide and Cidofovir – Are They Useful? Michelle A. Josephson, MD University of Chicago, Chicago, IL
7:50 am – 8:15 am	Monitoring Cellular Immune Response to BK Hans H. Hirsch, MD, MSc Institute for Medical Microbiology, Basel, Switzerland
Living Donor Liver Transplantation Chairs: Igal Kam, MD, University of Colorado, Denver, CO, and William Wall, MD, London Health Science Center, London, Canada
7:00 am – 7:25 am	Living Donor Liver Transplantation: The Asian Experience Chung Mau Lo, MD University of Hong Kong, Hong Kong, China
7:25 am – 7:50 am	Update of the A2ALL Experience (NIH Consortium) Jean C. Emond, MD Columbia University, New York, NY
7:50 am – 8:15 am	Canadian Experience in Adult Living Donor Liver Transplantation David R. Grant, MD Toronto Western Hospital, Toronto, Canada
Early Morning Workshops 7:00 am – 8:15 am
Xenotransplantation: Are We Getting Closer? Co-chairs: Leo Buhler, MD, University Hospital of Geneva, Switzerland and Emanuele Cozzi, MD, PhD, Padua General Hospital,Padua, Italy B Cells: Barrier or Path to Graft Acceptance? Co-chairs: Anita S. F. Chong, PhD, University of Chicago, Chicago, IL and William M. Baldwin III, MD, PhD, Baltimore, MD Chemokines: Clinical Targets Co-chairs: Robert L. Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH and Wayne W. Hancock, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA Retransplantation of Thoracic Organs – Reaching Consensus Co-chairs: Maryl R. Johnson, MD, University of Wisconsin-Madison, Madison, WI and Kenneth McCurry, MD, University of Pittsburgh, Pittsburgh, PA Non-medical Causes of Renal Allograft Loss Co-chairs: Mark A. Schnitzler, PhD, Saint Louis University School of Medicine, St Louis, MO and Ross Isaacs, MD, University of Virginia School of Medicine, Charlottesville, VA Intestinal and Multi-visceral Transplantation: Are We Still Making Progress? Co-chairs: Thomas M. Fishbein, MD, Georgetown University Hospital,Washington, DC and Stuart S. Kaufman, MD, Georgetown University,Washington, DC Approach to Parasitic Infections in Transplant Recipients and Donors Co-chairs: Camille Kotton, MD, Massachusetts General Hospital, Boston, MA and Michele Morris, MD, University of Miami, Miami Beach, FL Pediatric Renal Transplantation: Dealing with Recurrent Disease Co-chairs: Mark R. Benfield, MD, University of Alabama at Birmingham, Birmingham, AL and Ruth A. McDonald, MD, Children's Hospital and Regional Health Center, Seattle,WA
Joint Plenary and Awards 8:30 am – 10:00 am
10:00 am – 10:15 am	Break
Concurrent Symposia 11:00 am – 12:30 pm
What's Hot, What's New 12:00 nn – 1:00 pm Basic: Richard N. Pierson, III, MD Cilinical: R. Mark Ghobrial, MD, PhD

ATC PROGRAM

Sunday, June 1, 2008

Sunrise Symposia

Renal Transplant Clinical Pathology

mTOR and Vascular Biology: Discovery to Translation

Pancreas Alone Vs. Islet Transplantation – Current Controversies

Assessment and Clinical Considerations of New Histocompatibility Tests for Antibody Identification (HLA/Non- HLA) and Crossmatching

Early Morning Workshops

Joint Plenary and Awards

State-of-the-Art Address

Concurrent Symposia

Living Donation: A Critical Analysis

Nanomedicine: Can Tiny Devices Solve Big Problems in Transplantation?

Regulatory T Cells and theControl of Immunity

Modifying Ischemia-Reperfusion Injury for Graft Survival

Industry-supported Satellite Symposia – with lunch

Concurrent Sessions

Poster Session II

Monday, June 2

Sunrise Symposia

Hepatocellular Carcinoma in Liver Transplantation

Assessing Cardiovascular Risk Before and After Transplantation

Innate Immunity in Transplantation

Basic Science of New Therapeutic Targets in Posttransplantation Malignancies

Early Morning Workshops

Joint Plenary Session

Canadian Anniversary Celebration

Concurrent Symposia

Micro RNAi and Control of Lymphocyte Development

Progress in Moving Transplantation Tolerance to the Clinic

Pre-emptive Kidney Transplantation

Hepatitis C: Are We Really Making Progress?

Industry-supported Satellite Symposia – with lunch

Concurrent Sessions

Poster Session III

AST Business Meeting

Tuesday, June 3

Sunrise Symposia

Update in B-cell Tolerance

Pediatrics: Are Children Suitable Candidates for Tolerance Regimens?

Fellowship Training of the Transplant Specialist

Lung Transplantation: Hot Topics

Early Morning Workshops

Joint Plenary and Awards

State-of-the-Art Address

Presidential Addresses

ASTS and AST Distinguished Service Awards

Industry-supported Satellite Symposia – with lunch

Concurrent Sessions

Poster Session IV

ASTS Business Meeting

Wednesday, June 4

Sunrise Symposia

Canadian Perspectives on Clinical Transplantation

Randomized Clinical Trials (RCT's) in Heart Transplantation

Polyomavirus

Living Donor Liver Transplantation

Early Morning Workshops

Joint Plenary and Awards

Concurrent Symposia

What's Hot, What's New